
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Endocyte is a biopharmaceutical company and leader in developing targeted therapies for the personalized treatment of cancer. The companys drug conjugation technology targets therapeutics and companion imaging agents specifically to the site of diseased cells. Endocytes lead program is a prostate specific membrane antigen (PSMA)-targeted radioligand therapy, 177Lu-PSMA-617, entering phase 3 for metastatic castration resistant prostate cancer (mCRPC). Endocyte is also advancing its adaptor-controlled CAR T-cell therapy into the clinic, where it will be studied in osteosarcoma
Cancer,mcrpc,car-t,targeted drug therapy,and companion imaging
Endocyte operates in the Pharmaceutical manufacturing industry.
Endocyte's revenue is 11m - 100m
Endocyte has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.